Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Castle Biosciences, Inc. (CSTL) had Operating Cash Flow per Share of $-0.21 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$87.99M |
|
$-25.85M |
|
$16.38M |
|
$71.61M |
|
$115.92M |
|
$-27.93M |
|
$1.66M |
|
$-26.27M |
|
$-26.27M |
|
$-25.85M |
|
$-25.85M |
|
$-25.85M |
|
$-25.85M |
|
$-27.93M |
|
$0.40M |
|
28.61M |
|
28.61M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$349.39M |
|
$55.42M |
|
$152.33M |
|
$501.71M |
|
$37.27M |
|
$8.92M |
|
$24.14M |
|
$61.41M |
|
$440.31M |
|
$362.40M |
|
$440.31M |
|
28.84M |
|
| Cash Flow Statement Financials | |
$-6.04M |
|
$-22.43M |
|
$-1.55M |
|
$119.71M |
|
$89.69M |
|
$-30.02M |
|
$11.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.37 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
81.38% |
|
-31.74% |
|
-31.74% |
|
-- |
|
-29.86% |
|
-29.38% |
|
$-10.77M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
2.39 |
|
1.56 |
|
57.64 |
|
-5.87% |
|
-7.13% |
|
-5.15% |
|
-5.75% |
|
$15.26 |
|
$-0.38 |
|
|
Operating Cash Flow per Share |
$-0.21 |